美国大众公司使用人工智能将药物开发的时间缩短一半. J&J uses AI to cut drug development lead time in half.

根据公司首席信息官的说法, 约翰逊和约翰逊正在使用人工智能来将产生潜在药物开发线索所需时间缩短一半. Johnson & Johnson is using artificial intelligence to cut the time needed to generate potential drug development leads by half, according to the company’s chief information officer. 虽然人工智能还不能自行发现药物,但该公司正在使用这项技术来选化学化合物并简化监管文件准备工作,从而大大加速了研究过程. While AI cannot yet discover drugs on its own, the company is using the technology to screen chemical compounds and streamline regulatory document preparation, significantly accelerating the research process.